NEW YORK (GenomeWeb) — Diversigen and Norgen Biotek said today that they have signed an agreement to combine their respective services into a single end-to-end offering for microbiome research.
Diversigen provides microbiome and metagenomics consulting, sequencing, and data analysis services, while Norgen sells products for RNA, DNA, and protein purification, as well as next-generation sequencing sample prep.
Through their strategic alliance, the companies will market sample collection, ambient temperature sample stabilization, nucleic acid purification, and bioinformatic and data analysis products and services, as well as NGS library prep kits. The offering will specifically target DNA and RNA sequencing and analysis for bacterial, fungal, and viral communities, host RNA, and metatranscriptomics.
Additional terms of the deal were not disclosed.
"The partnership extends Diversigen's capabilities into sample handling and stabilization," Diversigen CEO Caroline Popper said in a statement. "Further, the Norgen offerings complement Diversigen's robust sequencing and data analytic pipelines."